Literature DB >> 9637792

The Environmental Genome Project: functional analysis of polymorphisms.

F P Guengerich1.   

Abstract

The ultimate goal of the Environmental Genome Project is the improvement of human health on the basis of information about the variations in certain genes. The first phase of the project will involve the selection of the human genes and characterization of the alleles occurring in the American population. However, intelligent use of this information will require analysis of the relevance of the allelic differences. Epidemiology alone will not solve the problem, and mechanistic studies will be required. Factors to be considered in the design of functional analyses are considered in this commentary.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9637792      PMCID: PMC1533131          DOI: 10.1289/ehp.98106365

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  30 in total

1.  Aflatoxin B1 8,9-epoxide hydrolysis in the presence of rat and human epoxide hydrolase.

Authors:  W W Johnson; H Yamazaki; T Shimada; Y F Ueng; F P Guengerich
Journal:  Chem Res Toxicol       Date:  1997-06       Impact factor: 3.739

2.  Epidemiology faces its limits.

Authors:  G Taubes
Journal:  Science       Date:  1995-07-14       Impact factor: 47.728

3.  High organochlorine body burden in women with estrogen receptor-positive breast cancer.

Authors:  E Dewailly; S Dodin; R Verreault; P Ayotte; L Sauvé; J Morin; J Brisson
Journal:  J Natl Cancer Inst       Date:  1994-02-02       Impact factor: 13.506

4.  Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9.

Authors:  A E Rettie; L C Wienkers; F J Gonzalez; W F Trager; K R Korzekwa
Journal:  Pharmacogenetics       Date:  1994-02

Review 5.  A critical review of the genotoxic potential of electric and magnetic fields.

Authors:  J McCann; F Dietrich; C Rafferty; A O Martin
Journal:  Mutat Res       Date:  1993-07       Impact factor: 2.433

6.  Development and field-test validation of an assay for DNA repair in circulating human lymphocytes.

Authors:  W F Athas; M A Hedayati; G M Matanoski; E R Farmer; L Grossman
Journal:  Cancer Res       Date:  1991-11-01       Impact factor: 12.701

7.  Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1.

Authors:  K A McGlynn; E A Rosvold; E D Lustbader; Y Hu; M L Clapper; T Zhou; C P Wild; X L Xia; A Baffoe-Bonnie; D Ofori-Adjei
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

8.  Breast cancer and serum organochlorines: a prospective study among white, black, and Asian women.

Authors:  N Krieger; M S Wolff; R A Hiatt; M Rivera; J Vogelman; N Orentreich
Journal:  J Natl Cancer Inst       Date:  1994-04-20       Impact factor: 13.506

9.  Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps.

Authors:  N P Lang; M A Butler; J Massengill; M Lawson; R C Stotts; M Hauer-Jensen; F F Kadlubar
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1994-12       Impact factor: 4.254

Review 10.  Toxicological approaches to complex mixtures.

Authors:  J L Mauderly
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

View more
  16 in total

1.  A bold new direction for environmental health research.

Authors:  K Olden; J Guthrie; S Newton
Journal:  Am J Public Health       Date:  2001-12       Impact factor: 9.308

2.  Pharmacogenomics. Interview by Clare Thompson.

Authors:  W Sadee's
Journal:  BMJ       Date:  1999-11-13

3.  Shifting paradigm of association studies: value of rare single-nucleotide polymorphisms.

Authors:  Ivan P Gorlov; Olga Y Gorlova; Shamil R Sunyaev; Margaret R Spitz; Christopher I Amos
Journal:  Am J Hum Genet       Date:  2008-01       Impact factor: 11.025

4.  Pharmacogenomics.

Authors:  W Sadée
Journal:  West J Med       Date:  1999-11

Review 5.  Pharmacogenomics: the promise of personalized medicine.

Authors:  L Mancinelli; M Cronin; W Sadée
Journal:  AAPS PharmSci       Date:  2000

Review 6.  Postgenomic chemical ecology: from genetic code to ecological interactions.

Authors:  May R Berenbaum
Journal:  J Chem Ecol       Date:  2002-05       Impact factor: 2.626

7.  Inherited alterations of TGF beta signaling components in Appalachian cervical cancers.

Authors:  Thomas J Knobloch; Juan Peng; Erinn M Hade; David E Cohn; Mack T Ruffin; Michael A Schiano; Byron C Calhoun; William C McBee; Jamie L Lesnock; Holly H Gallion; Jondavid Pollock; Bo Lu; Steve Oghumu; Zhaoxia Zhang; Marta T Sears; Blessing E Ogbemudia; Joseph T Perrault; Logan C Weghorst; Erin Strawser; Cecilia R DeGraffinreid; Electra D Paskett; Christopher M Weghorst
Journal:  Cancer Causes Control       Date:  2019-08-21       Impact factor: 2.506

8.  The Environmental Polymorphisms Registry: a DNA resource to study genetic susceptibility loci.

Authors:  Patricia C Chulada; Heather L Vahdat; Richard R Sharp; Tracy C DeLozier; Paul B Watkins; Susan N Pusek; Perry J Blackshear
Journal:  Hum Genet       Date:  2008-01-10       Impact factor: 4.132

9.  Gene-environment interactions in the development of complex disease phenotypes.

Authors:  Rosemarie G Ramos; Kenneth Olden
Journal:  Int J Environ Res Public Health       Date:  2008-03       Impact factor: 3.390

10.  Knowledge building insights on biomarkers of arsenic toxicity to keratinocytes and melanocytes.

Authors:  Raphael D Isokpehi; Udensi K Udensi; Matthew N Anyanwu; Andreas N Mbah; Matilda O Johnson; Kafui Edusei; Michael A Bauer; Roger A Hall; Omotayo R Awofolu
Journal:  Biomark Insights       Date:  2012-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.